BME News

The Department of Biomedical Engineering at Rensselaer Polytechnic Institute has established a new master’s degree program that will prepare students for careers of biomedical data science, a fast growing engineering specialty.Those with expertise in biomedical data science are already in high demand, and that demand will  continue to rise in the future, said Juergen Hahn, Ph.D., head of the Biomedical Engineering Department.

Six RPI students have been awarded fellowships from the National Science Foundation’s Graduate Research Fellowship Program (GRFP).

Joan Llabre, Ph.D. '23, who received her doctorate in biomedical engineering from Rensselaer Polytechnic Institute this past fall and is now a postdoctoral researcher at the Institute, has won the Koerner Family Foundation Fellowship, which supports engineers pursuing careers in research. 

Using artificial intelligence tools to analyze years of biomedical data, researchers at Rensselaer Polytechnic Institute have discovered a possible connection between sleep, gastrointestinal health, and two potentially harmful behaviors often associated with profound autism: self-injury and aggression. Their study is published in the Journal of Personalized Medicine.

This spring, a team of biomedical engineering students at Rensselaer Polytechnic Institute helped create a critical component that may be used to diagnose skin cancer rapidly and at the point of care, pending FDA clearance.

Rensselaer Polytechnic Institute has established the Office of Strategic Alliances and Translation, a new area within the university that incorporates a number of key translational activities at RPI, including intellectual property and technology licensing, large-scale corporate partnerships, initiation and growth of start-up ventures, and translational campuses, including the Rensselaer Technology Park, as well as translational activities in New York City.

This past summer, a team of Rensselaer Polytechnic Institute students, with the guidance of a faculty mentor, pitched a winning design for a wearable, medical-grade device that monitors for atrial fibrillation. Atrial fibrillation, or A-fib, is a potentially life-threatening heart condition that will affect an estimated 12 million people in the U.S. by 2030, according to the Centers for Disease Control and Prevention. 

Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes.

High school students in upstate New York have their pick of colleges and universities within driving distance, and some choose to head to nearby states such as Massachusetts, Connecticut, Vermont, or New Hampshire. However, many students choose Rensselaer Polytechnic Institute (RPI), a technological research institution with a global reach that also happens to be local.

Recently, more than 30 undergraduate students from Rensselaer Polytechnic Institute gathered at the Center for Biotechnology and Interdisciplinary Studies to share their findings with the community.

Steven Cramer, professor in the Isermann Department of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, has been named Institute Professor, one of the highest and most prestigious honors bestowed upon a Rensselaer faculty member.

The grand opening of the Center for Engineering and Precision Medicine (CEPM), a partnership between Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), was held March 29, 2023 at the Hudson Research Center (HRC) at 619 West 54th Street.

In a perspective article published today in Nature Machine Intelligence, researchers at Rensselaer Polytechnic Institute (RPI) Drs. Ge Wang, Pingkun Yan, and Chuang Niu presented “Medical Technology and AI (MeTAI)” in the metaverse that promises to develop new intelligent health care. This represents a multidisciplinary collaboration among academic and clinical researchers with University of Chicago, Johns Hopkins University, Stony Brook University, industrial leaders from GE Healthcare and Canon Medical Research, and regulatory experts at the FDA and Puente Solutions.